A regulatory mechanism for RSK2 NH(2)-terminal kinase activity.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Research

• Publication date

  2009-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-08-4959PMID 19435896PMCID PMC2822654
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization, HPLC method development and impurity identification for 3,4,3-LI(1,2-HOPO), a potent actinide chelator for radionuclide decorporation.

  2015cited by this paper
• Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation.

  2007influential reference
• Crystal structures of the N‐terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitors

  2007influential reference
• RSK2 Mediates Muscle Cell Differentiation through Regulation of NFAT3*

  2007cited by this paper
• Homology model of RSK2 N-terminal kinase domain, structure-based identification of novel RSK2 inhibitors, and preliminary common pharmacophore.

  2006cited by this paper
• The p53 protein is a novel substrate of ribosomal S6 kinase 2 and a critical intermediary for ribosomal S6 kinase 2 and histone H3 interaction.

  2005cited by this paper
• Essential role of RSK2 in c-Fos-dependent osteosarcoma development.

  2005cited by this paper
• Synergistic antiproliferative action of the flavonols quercetin and kaempferol in cultured human cancer cell lines.

  2005cited by this paper
• Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation.

  2005cited by this paper
• The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation.

  2005cited by this paper
• ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome.

  2004cited by this paper
• Absorption and metabolism of flavonoids.

  2004cited by this paper
• Augmentation of differentiation and gap junction function by kaempferol in partially differentiated colon cancer cells.

  2004cited by this paper
• ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions

  2004cited by this paper
• Absorption of kaempferol from endive, a source of kaempferol-3-glucuronide, in humans

  2004cited by this paper
• A Novel Role for Mixed-Lineage Kinase-Like Mitogen-Activated Protein Triple Kinase α in Neoplastic Cell Transformation and Tumor Development

  2004cited by this paper
• Mitogen-Activated Protein Kinase Activation in UV-Induced Signal Transduction

  2003cited by this paper
• Kaempferol‐induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK‐MAPK

  2003cited by this paper
• ERK5 and ERK2 Cooperate to Regulate NF-κB and Cell Transformation*

  2001cited by this paper
• ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation.

  2001cited by this paper
• Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants.

  2001cited by this paper
• Development of anticancer drugs targeting the MAP kinase pathway

  2000cited by this paper
• ERKs and p38 Kinases Mediate Ultraviolet B-induced Phosphorylation of Histone H3 at Serine 10*

  2000cited by this paper
• A phosphoserine‐regulated docking site in the protein kinase RSK2 that recruits and activates PDK1

  2000influential reference
• Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3.

  1999cited by this paper
• Perspectives: signal transduction. Cell survival demands some Rsk.

  1999cited by this paper
• Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers

  1999cited by this paper
• Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms.

  1999cited by this paper
• Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction.

  1999cited by this paper
• SIGNAL TRANSDUCTION:Cell Survival Demands Some Rsk

  1999cited by this paper
• Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β‐glucosidase activity

  1998cited by this paper
• Mutation analysis of the RSK2 gene in Coffin-Lowry patients: extensive allelic heterogeneity and a high rate of de novo mutations.

  1998cited by this paper
• Coupling of the RAS-MAPK Pathway to Gene Activation by RSK2, a Growth Factor-Regulated CREB Kinase

  1996cited by this paper
• Transcriptional regulation by MAP kinases

  1995cited by this paper
• Signal transduction via the MAP kinases: proceed at your own RSK.

  1993cited by this paper
• Identification of cell cycle-regulated phosphorylation sites on nuclear lamin C.

  1990cited by this paper
• A Xenopus ribosomal protein S6 kinase has two apparent kinase domains that are each similar to distinct protein kinases.

  1988influential reference

• Phosphorylation status and prognostic impacts of RSK2, PDPK1, and AKT in malignant lymphoma

  2025cites this paper
• Anticancer Potential of Polyphenols in Legumes: Mechanisms and Insights.

  2025cites this paper
• RSK2 and its binding partners: an emerging signaling node in cancers

  2025influential citation
• Ribosomal S6 kinase 2-forkhead box protein O4 signaling pathway plays an essential role in melanogenesis

  2024cites this paper
• RSK inhibitors as potential anticancer agents: Discovery, optimization, and challenges.

  2023cites this paper
• P90 ribosomal S6 kinases: a bona fide target for novel targeted anticancer therapies?

  2023cites this paper
• Therapeutic Importance of Kaempferol in the Treatment of Cancer through the Modulation of Cell Signalling Pathways

  2022cites this paper
• Novel wiring of the AKT-RSK2 signaling pathway plays an essential role in cancer cell proliferation via a G1/S cell cycle transition.

  2022cites this paper
• Kaempferol sensitizes cell proliferation inhibition in oxaliplatin-resistant colon cancer cells

  2021cites this paper
• Discovery of novel p90 ribosomal S6 kinase 2 inhibitors for potential cancer treatment through ligand-based and structure-based virtual screening methods

  2021cites this paper
• RSK2 protects human breast cancer cells under endoplasmic reticulum stress through activating AMPKα2-mediated autophagy

  2020cites this paper
• Serine‐227 in the N‐terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma

  2020cites this paper
• In vitro antimicrobial, antioxidant and anticancer activities of globe artichoke (Cynara cardunculus var. scolymus L.) bracts and receptacles ethanolic extract

  2020cites this paper
• RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity

  2019cites this paper
• RSK2 is required for TRAF6 phosphorylation-mediated colon inflammation

  2018cites this paper
• Augmented Cell Signaling by Natural Polyphenols and Flavonoids: Insights Into Cancer Cell Remodeling and Prevention

  2018cites this paper
• Kaempferol targeting on the fibroblast growth factor receptor 3-ribosomal S6 kinase 2 signaling axis prevents the development of rheumatoid arthritis

  2018cites this paper
• Molecular Targeting of ERKs/RSK2 Signaling in Cancers.

  2017cites this paper
• Plant-Derived Compounds with Anticancer Properties: From Folklore to Practice

  2017cites this paper
• Osajin inhibits solar UV-induced cyclooxygenase-2 expression through direct inhibition of RSK 2 † Running title : Inhibition of RSK 2 by Osajin

  2017cites this paper
• Osajin Inhibits Solar UV‐Induced Cyclooxygenase‐2 Expression Through Direct Inhibition of RSK2

  2017cites this paper
• RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth

  2017cites this paper
• Ribosomal S6 kinase (RSK) modulators: a patent review

  2016cites this paper
• RSK2 and its binding partners in cell proliferation, transformation and cancer development

  2016cites this paper
• Bacterial Expression, Purification and In Vitro Phosphorylation of Full-Length Ribosomal S6 Kinase 2 (RSK2)

  2016cites this paper
• Effect of Glucuronidation on the Potential of Kaempferol to Inhibit Serine/Threonine Protein Kinases.

  2016cites this paper
• The influence of phase II conjugation on the biological activity of flavonoids

  2016cites this paper
• Kaempferol stimulates gene expression of low-density lipoprotein receptor through activation of Sp1 in cultured hepatocytes

  2016cites this paper
• Challenges in Docking: Mini Review

  2016cites this paper
• Role of novel histone modifications in cancer

  2015cites this paper
• Molecular Targeting of ERKs/RSK2 Signaling Axis in Cancer Prevention

  2015cites this paper
• Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway

  2015influential citation
• Computational and Biochemical Discovery of RSK2 as a Novel Target for Epigallocatechin Gallate (EGCG)

  2015cites this paper
• Silkworm Thorn Stem Extract Targets RSK2 and Suppresses Solar UV-Induced Cyclooxygenase-2 Expression

  2015cites this paper
• Cytotoxic activity of flavonoid extracts from Lepidium sativum ( Brassicaceae ) seeds and leaves

  2015cites this paper
• Targeting of magnolin on ERKs inhibits Ras/ERKs/RSK2-signaling-mediated neoplastic cell transformation.

  2014cites this paper
• Kaempferol Targets RSK2 and MSK1 to Suppress UV Radiation-Induced Skin Cancer

  2014cites this paper
• PHYTOCHEMICAL AND CYTOTOXIC STUDIES OF POLYPHENOLIC FLAVONOIDS CONTENTS OF URTICA DIOICA

  2014cites this paper
• Kaempferol, a potential cytostatic and cure for inflammatory disorders.

  2014cites this paper
• Fibroblast and Epidermal Growth Factors Utilize Different Signaling Pathways to Induce Anchorage-independent Cell Transformation in JB6 Cl41 Mouse Skin Epidermal Cells

  2014cites this paper
• A Rising Cancer Prevention Target of RSK2 in Human Skin Cancer

  2013cites this paper
• RSK2-induced stress tolerance enhances cell survival signals mediated by inhibition of GSK3β activity.

  2013cites this paper
• Signal Transduction and Molecular Targets of Selected Flavonoids

  2013cites this paper
• A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention.

  2013cites this paper
• Synthesis, activity evaluation, and docking analysis of barbituric acid aryl hydrazone derivatives as RSK2 inhibitors

  2013cites this paper
• Identification of quercitrin as an inhibitor of the p90 S6 ribosomal kinase (RSK): structure of its complex with the N-terminal domain of RSK2 at 1.8 Å resolution.

  2013cites this paper
• A chrysin derivative inhibits cell transformation

  2013cites this paper
• IN VITRO ISPITIVANJE ANTITUMORSKE AKTIVNOSTI EKSTRAKATA ENDEMIČNE BILJNE VRSTE Helichrysum zivojinii Černjavski et Soška

  2013cites this paper
• Signal Transduction and Molecular Targets of Dietary Cancer-Preventive Phytochemicals

  2013cites this paper
• A Chrysin Derivative Suppresses Skin Cancer Growth by Inhibiting Cyclin-dependent Kinases*

  2013cites this paper
• Prediction of Molecular Targets of Cancer Preventing Flavonoid Compounds Using Computational Methods

  2012cites this paper
• Tumor Necrosis Factor Receptor-associated Factor Family Protein 2 Is a Key Mediator of the Epidermal Growth Factor-induced Ribosomal S6 Kinase 2/cAMP-responsive Element-binding Protein/Fos Protein Signaling Pathway*

  2012cites this paper
• RSK2 as a key regulator in human skin cancer.

  2012influential citation
• Histone phosphorylation

  2012cites this paper
• Molecular targets of phytochemicals for cancer prevention

  2011cites this paper
• Identification of Inhibitors against p90 Ribosomal S6 Kinase 2 (RSK2) through Structure-Based Virtual Screening with the Inhibitor-Constrained Refined Homology Model

  2011cites this paper
• Outstanding challenges in protein–ligand docking and structure‐based virtual screening

  2011cites this paper
• Effects of Dietary Effectors on Signal Transduction Pathways Related to Cancer Prevention

  2011cites this paper
• A review on the dietary flavonoid kaempferol.

  2011cites this paper
• Phosphorylation of Histone H2B Serine 32 Is Linked to Cell Transformation*

  2011cites this paper
• Polyphenols as small molecular inhibitors of signaling cascades in carcinogenesis.

  2011cites this paper
• SHAFTS: a hybrid approach for 3D molecular similarity calculation. 2. Prospective case study in the discovery of diverse p90 ribosomal S6 protein kinase 2 inhibitors to suppress cell migration.

  2011cites this paper
• Studies on the chemical constituents of fresh leaf of Eruca sativa extract and its biological activity as anticancer agent in vitro .

  2011cites this paper
• Challenges and advances in computational docking: 2009 in review

  2011cites this paper
• RSK2 Binding Models Delineate Key Features for Activity.

  2010cites this paper
• Phosphatidylinositol 3-kinase, a novel target molecule for the inhibitory effects of kaempferol on neoplastic cell transformation.

  2010cites this paper
• Eriodictyol Inhibits RSK2-ATF1 Signaling and Suppresses EGF-induced Neoplastic Cell Transformation*

  2010cites this paper
• Update on Cancer Prevention Research in the United States and China: The 2009 China—U.S. Forum on Frontiers of Cancer Research

  2010cites this paper
• Cellular and Molecular Life Sciences the Role of Genetics in the Establishment and Maintenance of the Epigenome

  year unknowncites this paper
• Targeting of Magnolin on Erks Inhibits Ras/erks/rsk2-signaling-mediated Neoplastic Cell Transformation Mitogen-activated Protein Kinases Play a Key Role in Cell Prolifera- Tion, Cell Cycle Progression and Cell Transformation, and Activated Ras/extracellular Signal-regulated Kinases (erks)/ribosomal

  year unknowncites this paper